Workflow
PharmaBlock Sciences (Nanjing) (300725)
icon
Search documents
药石科技(300725.SZ)股东周全拟合计减持不超232.96万股
智通财经网· 2025-09-18 11:22
智通财经APP讯,药石科技(300725.SZ)公告,公司股东周全女士计划在2025年9月24日至2025年12月23 日以集中竞价方式或大宗交易方式减持公司股份不超过232.96万股,占公司剔除已回购股份后总股本比 例1%。 ...
药石科技:股东拟减持不超1%公司股份
人民财讯9月18日电,药石科技(300725)9月18日公告,持股2.51%的股东周全计划通过集中竞价或大 宗交易方式减持不超过232.96万股,占公司剔除已回购股份后总股本比例1%。减持原因系个人资金需 求。 ...
药石科技:周全拟减持不超1%股份
南财智讯9月18日电,药石科技公告,股东周全计划自2025年9月24日至2025年12月23日,通过集中竞价 或大宗交易方式减持公司股份不超过232.96万股,占公司剔除已回购股份后总股本的1%。周全女士目 前持有公司584.909万股,占剔除已回购股份后总股本的2.51%。此次减持是出于个人资金需求。周全女 士持有的股份来源于婚姻关系解除进行的财产分割,且将继续履行相关承诺。周全女士不属于公司5% 以上股东,亦非公司控股股东、实际控制人或其一致行动人,不在公司担任董事、监事、高级管理人员 职务。本次减持计划不会导致公司控制权变更,也不会对公司治理结构和持续经营产生影响。 ...
药石科技(300725) - 关于公司股东减持股份的预披露公告
2025-09-18 10:52
证券代码:300725 证券简称:药石科技 公告编号:2025-092 南京药石科技股份有限公司 关于公司股东减持股份的预披露公告 公司股东周全保证向本公司提供的信息内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示: 持有本公司股份5,849,090股(占剔除已回购股份后总股本比例2.51%)的股东周全 女士计划在2025年9月24日至2025年12月23日以集中竞价方式或大宗交易方式减持本公 司股份不超过2,329,600股,占公司剔除已回购股份后总股本比例1%。 一、股东情况 (一)股东名称:周全 (四)减持方式:集中竞价交易或大宗交易等深圳证券交易所认可的合法方式。 (五)减持期间:减持股份计划公告披露之日起3个交易日后的3个月内进行,即 2025年9月24日至2025年12月23日。 (六)减持价格区间:根据减持时的二级市场价格及交易方式确定。 (七)股东承诺履行情况:周全女士承诺其通过离婚财产分割取得的公司股份, 将继续履行吴希罕先生在公司《首次公开发行股票并在创业板上市招股说明书》中的承 诺:"未来本人减持股 ...
9月17日生物经济(970038)指数跌0.55%,成份股药石科技(300725)领跌
Sou Hu Cai Jing· 2025-09-17 10:48
Group 1 - The Biotech Index (970038) closed at 2403.29 points, down 0.55%, with a trading volume of 25.269 billion yuan and a turnover rate of 1.59% [1] - Among the index constituents, 11 stocks rose, led by Jingxin Pharmaceutical with a 2.67% increase, while 38 stocks fell, with Yaoshi Technology leading the decline at 5.11% [1] - The top ten constituents of the Biotech Index include major companies such as Mindray Medical, with a weight of 13.82% and a market cap of 290.246 billion yuan, and other notable firms like Tigermed and Changchun High-tech [1] Group 2 - The net outflow of main funds from the Biotech Index constituents totaled 1.789 billion yuan, while retail investors saw a net inflow of 1.354 billion yuan [3] - Specific stocks like Boteng Co. experienced a net inflow of 73.5819 million yuan from main funds, while others like Jiayin Pharmaceutical saw a net outflow of 4.8669 million yuan [3] - The overall trend indicates a mixed sentiment among institutional and retail investors, with significant movements in individual stocks reflecting varying levels of confidence [3]
午间公告:药石科技可转债即将停止转股
Group 1 - Yaoshi Technology's "Yaoshi Convertible Bonds" will stop conversion after the last half trading day on September 17, with remaining bonds being forcibly redeemed at a price of 100.62 CNY per bond [1] - Xinjiang Communications Construction's "Jiaojian Convertible Bonds" will stop trading after the market closes on September 17, with September 22 being the last conversion day [1]
药石科技(300725) - 关于药石转债即将停止转股暨赎回前最后半个交易日的重要提示性公告
2025-09-17 03:44
| 证券代码:300725 | 证券简称:药石科技 | 公告编号:2025-091 | | --- | --- | --- | | 债券代码:123145 | 债券简称:药石转债 | | 南京药石科技股份有限公司 关于药石转债即将停止转股暨赎回前最后半个交易日的 重要提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示: 1、最后转股日:2025 年 9 月 17 日 2、债券持有人若转股,需开通创业板交易权限。投资者不符合创业板股票 适当性管理要求的,不能将所持"药石转债"转换为股票,特提请投资者关注不 能转股的风险。 3、特提醒"药石转债"持有人注意在限期内转股。 特别提示: 1、"药石转债"赎回价格:100.62 元/张(债券面值加当期应计利息,当期 年利率为 1.5%,且当期利息含税),扣税后的赎回价格以中国证券登记结算有 限责任公司深圳分公司(以下简称"中国结算")核准的价格为准。 2、赎回条件满足日:2025 年 8 月 14 日 3、停止交易日:2025 年 9 月 15 日 4、赎回登记日:2025 年 9 月 17 日 5 ...
晚间公告丨9月16日这些公告有看头
第一财经· 2025-09-16 14:55
Core Viewpoint - Several listed companies in the Shanghai and Shenzhen stock markets announced significant developments, including financing arrangements, asset sales, and strategic partnerships, which may present investment opportunities and risks for investors [4][5][6][8][9][10]. Financing and Borrowing - Vanke A announced that its largest shareholder, Shenzhen Metro Group, will provide a loan of up to 2.064 billion yuan to repay bond principal and interest, with a loan term of no more than three years and a floating interest rate based on the LPR minus 66 basis points [4]. - Jianfeng Group obtained a loan commitment of up to 36 million yuan from China Merchants Bank for stock repurchase, with a loan term of no more than 36 months at an interest rate of 1.8% [11]. Asset Sales and Acquisitions - Angli Education plans to sell 100% of Kensington Park School Limited for 80,000 pounds (approximately 760,100 yuan) to alleviate financial pressure [5]. - Guang'an Aizhong intends to acquire 90% of Qitai Hengtai at a price of 0 yuan, with plans for further investment in renewable energy projects [12][13]. - Suzhou Planning aims to acquire 80% of Kunshan Development Zone Architectural Design Institute for 831,720 yuan [18]. Regulatory and Compliance Issues - Haohai Biotechnology's controlling shareholder received an administrative penalty notice from the CSRC for suspected insider trading, although it is stated that this will not significantly impact the company's operations [7]. - Yunding Technology received a warning letter from the Shandong Securities Regulatory Bureau for inaccurate financial disclosures in its 2015 annual report [8]. Performance and Forecasts - Brothers Technology expects a net profit of 100 million to 115 million yuan for the first three quarters of 2025, representing a year-on-year increase of 207.32% to 253.42%, driven by rising prices of certain vitamin products and improved production efficiency [21]. Strategic Partnerships and Contracts - Jiuzhou Yiqu signed a strategic cooperation agreement with China Electric Power Construction Group Chengdu Survey and Design Institute to enhance collaboration in the rail transit sector [22]. - Luxiao Technology's subsidiary signed a strategic cooperation agreement to develop AI service robots for the US and European markets, aiming to sell at least 1 million units by 2026-2028 [23]. - China Shipbuilding Technology signed a green methanol sales contract worth approximately 40 million USD per year, with potential increases based on customer demand [24]. Stock Transactions and Shareholder Actions - Several companies, including Maidi Technology and Xin Hua Co., announced plans for shareholders to reduce their stakes, with reductions ranging from 1.7% to 3% of total shares [29][30][31][34][35].
药石科技:关于药石转债即将停止转股暨赎回前最后一个交易日的重要提示性公告
Core Viewpoint - Yaoshi Technology announced a mandatory redemption of its convertible bonds at a price of 100.62 yuan per bond, effective after the market closes on September 17, 2025, due to significant discrepancies between the market price and the redemption price [1] Summary by Relevant Sections - **Convertible Bonds**: The "Yaoshi Convertible Bonds" will be forcibly redeemed at 100.62 yuan per bond if not converted by the specified date [1] - **Market Conditions**: The trading and conversion of "Yaoshi Convertible Bonds" have been halted, leading to a notable difference between the market price and the redemption price [1] - **Investor Advisory**: The company has issued a reminder for bondholders to convert their bonds within the deadline to avoid potential losses [1]
晚间公告丨9月16日这些公告有看头
Di Yi Cai Jing· 2025-09-16 10:40
Major Events - Angli Education plans to sell 100% equity of Kensington Park School Limited for £80,000 (approximately 760,100 RMB) to Hong Kong KS Education Group Limited to alleviate operational difficulties and reduce financial impact [1] Regulatory Actions - Haohai Biological's controlling shareholder, Jiang Wei, received an administrative penalty notice from the China Securities Regulatory Commission (CSRC) for suspected insider trading, which does not impact the company's daily operations or finances [2] - Yunding Technology received a warning letter from the Shandong Securities Regulatory Bureau for inaccurate information disclosure in its 2015 annual report, involving former executives who are now subject to administrative measures [3] Corporate Actions - Yaoshi Technology announced that the last day for conversion of Yaoshi convertible bonds is September 17, after which unconverted bonds will be forcibly redeemed at 100.62 RMB per bond, potentially leading to investment losses for investors [4] - Kanghui Pharmaceutical intends to change its stock abbreviation from "Kanghui Pharmaceutical" to "Kanghui Co., Ltd." [5] Strategic Partnerships - Jiuzhou Yitu signed a strategic cooperation agreement with China Electric Power Construction Group Chengdu Survey and Design Institute to enhance collaboration in the rail transit sector [6] - Luxiao Technology's subsidiary signed a strategic cooperation agreement to jointly develop AI service robots for the U.S. and European markets, aiming to sell at least 1 million units between 2026 and 2028 [6] - China Shipbuilding Technology signed a green methanol sales contract worth approximately $40 million per year, with potential increases based on customer demand, starting supply in 2028 [6] - Haon Automotive received a product designation notice for ADAS perception systems and radar systems, estimating total revenue of approximately 2.477 billion RMB over a 5-year project lifecycle, with mass production expected to start in April 2026 [6] Shareholding Changes - Medi Technology's shareholder, Weng Kang, plans to reduce his stake by up to 1.7% of the company's total shares, while another shareholder, Wu Di, intends to reduce his holdings by up to 0.0047% [7] - Xinhua Co., Ltd.'s director, Fang Junwei, plans to reduce his holdings by up to 75,200 shares, representing no more than 0.039% of the company's total shares [7]